More about
Bacterial Pneumonia
Clinical Guidance
Pneumonia
Other Respiratory Infections
Parapneumonic Effusions and Empyema
Clinical Guidance
Pneumonia
Nonresolving Pneumonia
Managing Nonresolving Pneumonia
Clinical Guidance
Pneumonia
Treatment and Management
Optimizing Antibiotic Therapy
Clinical Guidance
Pneumonia
Treatment and Management
Community-Acquired Pneumonia
Clinical Guidance
Pneumonia
Presentation and Diagnosis
Diagnosis of Pneumonia
Clinical Guidance
Pneumonia
Overview
Pulmonary Host Defenses
Clinical Guidance
Pneumonia
Overview
Definition and Classification of Respiratory Tract Infection
News
May 24, 2023
2 min read
Save
FDA approves new treatment for nosocomial pneumonia
The FDA has approved IV sulbactam-durlobactam to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex.
News
April 18, 2023
2 min read
Save
FDA committee unanimously recommends pneumonia antibiotic for adults
The FDA’s Antimicrobial Drugs Advisory Committee voted unanimously in favor of approving sulbactam-durlobactam for adults with hospital-acquired and ventilator-associated bacterial pneumonia, Innoviva announced Monday.
News
October 18, 2022
2 min read
Save
Iron deficiency anemia did not worsen outcomes in patients hospitalized with bacterial pneumonia
NASHVILLE, Tenn. — Patients who were hospitalized with bacterial pneumonia with co-existing iron deficiency anemia did not have worse outcomes, including mortality, septic shock, acute respiratory failure and cardiac arrest.